Surgical Checklists Reduce Risk of Complications, Readmission and Additional Procedures: Study

|

The findings of a new study highlight the importance of hospitals adopting and enforcing the use of surgical checklists, indicating that a new patient safety system was effective in reducing the rate of complications, readmissions and repeat surgical procedures among patients.

Norwegian researchers determined the Surgical Patient Safety System (SURPASS) was effective when it was added to the World Health Organizations (WHO) existing surgical safety checklist (SSC), according to a report published this week in the medical journal JAMA Surgery.

The study evaluated data from a Norwegian hospital where the SURPASS checklists were implemented in three surgical departments. including neurosurgery, orthopedics, and gynecology.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Researchers studied the outcomes of more than 9,000 clinical surgical procedures involving SURPASS checklists and compared them to more than 9,600 surgeries where the checklists were not employed.

According to the findings, the SURPASS checklist helped reduce complications and emergency pre-operations. Adding the SURPASS checklist also helped reduce readmissions to the hospital following discharge from surgery. There was no difference in death rates after adding the new checklist.

The findings indicate the addition of the checklist reduced the risk of surgical complications by about 30%, reduced the need of reoperations by more than half, and decreased the rate of readmissions by about two-thirds.

Overall, surgical safety checklists are shown to help improve patient outcomes in surgery. The World Health Organization surgical safety checklist is now mandatory in many countries around the world.

The SURPASS checklist is individualized to be performed by specific doctors or nurses during preoperative and postoperative procedures. They are used as a last point of check before transferring a patient to the next step in the surgical procedure.

When clinicians adhered to the SURPASS checklist there was a decrease in in-hospital complications and emergency re-operations. Among control patients, complications increased, but re-operations, readmissions, and mortality remained unchanged.

“Findings from this study demonstrate that adding the preoperative and postoperative SURPASS checklists to the intraoperative WHO SSC may be clinically advantageous,” the researchers concluded. “We found that the joint application of the 2 surgical checklist systems was associated with reduced in-hospital complications, emergency reoperations, and hospital readmissions.”

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.